A Systematic Literature Review on the Cost-Effectiveness of Apixaban for Stroke Prevention in Non-valvular Atrial Fibrillation

@inproceedings{Pinyol2016ASL,
  title={A Systematic Literature Review on the Cost-Effectiveness of Apixaban for Stroke Prevention in Non-valvular Atrial Fibrillation},
  author={Carme Pinyol and Jose Mª Cepeda and Inmaculada Rold{\'a}n and Vanesa Rold{\'a}n and Silvia Jimenez and Paloma Gonz{\'a}lez and Javier Soto},
  booktitle={Cardiology and therapy},
  year={2016}
}
INTRODUCTION Economic evaluations are becoming increasingly important due to limitations in economic resources, the expense of many new treatments, the need to allocate health spending as effectively as possible, and the need to inform decision makers. Based on the data from the apixaban studies (ARISTOTLE and AVERROES), several economic evaluations have been performed in various countries to demonstrate the efficacy of apixaban versus warfarin and aspirin or other new oral anticoagulants… CONTINUE READING